Re-think rescue Tx: Consider options to target pathophysiology.

Detalles Bibliográficos
Publicado en:Dermatology Times Vol. 41; no. 1; pp. 1 - 3
Autor principal: HILTON, LISETTE
Formato: pictorial Journal Article
Publicado: MJH Life Sciences Jan2020
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=141290069&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 141290069
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        01966197
        DTI
      jtl: Dermatology Times
      issn: 01966197
      maglogo: N
    pubinfo:
      dt: Jan2020
      vid: 41
      iid: 1
      pid: 54670
      pub: MJH Life Sciences
      place: Cranbury, New Jersey
    artinfo:
      ui:
        141290069
        141290069
        141290069
        141290069
      ppf: 1
      ppct: 2
      formats:
      tig:
        atl: Re-think rescue Tx: Consider options to target pathophysiology.
      aug:
        au: HILTON, LISETTE
      sug:
        subj:
          Dermatitis, Atopic Drug Therapy
          Dermatitis, Atopic Physiopathology
          Dermatologists
          Antibodies, Monoclonal Therapeutic Use
          Physician-Patient Relations
          Biological Products Therapeutic Use
          Immunosuppressive Agents Therapeutic Use
          Immunosuppressive Agents Adverse Effects
          Patient Safety
          Biological Products Adverse Effects
      pubtype: Trade Publication
      doctype:
        pictorial
        Journal Article
      ougenre: Article
      ab:
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N